Abstract
Healthy diet behaviours are important in a globally ageing population, particularly in relation to cardiometabolic and brain health. The Eatwell guide (EWG) reflects the UK government’s recommendations for a healthy and balanced diet. Data from the PREVENT dementia cohort study baseline visit was used in this analysis. Binary and graded EWG scores (BEWG, GEWG) were created from a self-reported Food Frequency Questionnaire. The CAIDE score was included as the primary outcome measure to represent risk for future AD. Secondary outcome measures included cardiometabolic health measures, and brain health measures. Generalised additive models were run in R. A total of 517 participants were included in the analysis, with a mean BEWG score of 4.39 (±1.66) (out of a possible 12 points) and GEWG score of 39.88 (±6.19) (out of a possible 60 points). There was no significant association between either EWG score and the CAIDE (BEWG β: 0.07; p: 0.32; GEWG β: 0.02, p: 0.36) or any measures of brain health. There was a significant association between higher GEWG score and lower systolic and diastolic blood pressure and body mass index (BMI) (systolic β: -0.24, p: 0.03; diastolic β: -0.16, p: 0.01; BMI β: -0.09, p: 0.02). Although not directly associated with the CAIDE score, the EWG dietary pattern may be beneficial for dementia prevention efforts through modification of hypertension and obesity, which are both known risk factors for dementia. Future work could replicate these findings in other UK-based cohorts as well as further development of EWG scoring methodologies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
PREVENT is funded by the Alzheimers Society (grant numbers 178, 264 and 329), Alzheimers Association (grant number TriBEKa-17-519007) and philanthropic donations. The analytical work was funded by the MRC (MRC UK Nutrition Research Partnership (NRP) Collaboration Award NuBrain (MR/T001852/1). Prof. Muniz-Terrera acknowledges the support of the Osteopathic Heritage Foundation through funding for the Osteopathic Heritage Foundation Ralph S. Licklider, D.O., Research Endowment in the Heritage College of Osteopathic Medicine. The funders had no involvement in the protocol design, data collection, analysis or manuscript preparation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was conducted according to the guidelines laid down in the Declaration of Helsinki and all procedures involving human participants were approved by the London-Camberwell St Giles National Health Service Research Ethics Committee (REC reference 12/LO/1023). Written informed consent was provided by all participants prior to any protocol procedures.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.